| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/23/2006 | WO2006010634A8 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 03/23/2006 | WO2006010138A9 Bioactive chemokine heteromultimers |
| 03/23/2006 | WO2006005520A3 Means and methods for controlling flowering in plants |
| 03/23/2006 | WO2006003015A3 Improved enzymes |
| 03/23/2006 | WO2005116245A3 Cdna production from cells after laser microdissection |
| 03/23/2006 | WO2005116222A3 Gene-cassette for enhancement of protein production |
| 03/23/2006 | WO2005112541A3 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 03/23/2006 | WO2005110491A8 Inducible dimerization of growth factor receptors for treating cancer |
| 03/23/2006 | WO2005100602A3 Biosensor based on directed assembly of particles |
| 03/23/2006 | WO2005097981A3 Novel herpes simplex viruses |
| 03/23/2006 | WO2005095975A3 Anti-fungal target genes |
| 03/23/2006 | WO2005078094A3 Stabilized rnas as transfection controls and silencing reagents |
| 03/23/2006 | WO2005067368A3 Production of glucagon like peptide 2 and analogs |
| 03/23/2006 | WO2005059133A3 Combination therapy associating a tgf-breta antagonist with a chemiotherapeutic agent |
| 03/23/2006 | WO2005059111A3 DELIVERY OF DNA OR RNA VIA GAP JUNCTIONS FROM HOST CELLS TO TARGET CELLS AND A CELL-BASED DELIVERY SYSTEM FOR ANTISENSE OR SiRNA |
| 03/23/2006 | WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles |
| 03/23/2006 | WO2005048913A3 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 03/23/2006 | WO2005048692A3 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene |
| 03/23/2006 | WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 03/23/2006 | WO2005046585A3 Vps35-based assays and methods for treating alzheimer’s disease |
| 03/23/2006 | WO2005042743A3 Humanization of antibodies |
| 03/23/2006 | WO2005042006A3 Use of ephrins and related molecules to regulate cellular proliferation |
| 03/23/2006 | WO2005040340A3 Rnai-based modification of heterochromatin |
| 03/23/2006 | WO2005013886A3 Methods for treating and preventing apoptosis-related diseases using rna interfering agents |
| 03/23/2006 | WO2005013802A3 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 03/23/2006 | WO2005007623A8 Inhibition of syk kinase expression |
| 03/23/2006 | WO2005000201A3 Modulation of apolipoprotein (a) expression |
| 03/23/2006 | WO2004112721A3 Prevention or treatment of deficits that arise in connection with diseases of, or injuries to, the nervous system |
| 03/23/2006 | WO2004110340A3 Ctla-2 and uses thereof |
| 03/23/2006 | WO2004108939A3 BAV packaging regions and E1 transcriptional control regions |
| 03/23/2006 | WO2004104214A3 Methods and devices for multiplexing amplification reactions |
| 03/23/2006 | WO2004104180A3 Genes encoding carotenoid biosynthetic enzymes |
| 03/23/2006 | WO2004101799A3 Broadening adenovirus tropism |
| 03/23/2006 | WO2004065546A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1 |
| 03/23/2006 | WO2004005485A3 Compositions and methods for controlling parasitic nematodes |
| 03/23/2006 | WO2003083085A3 Transporters and ion channels |
| 03/23/2006 | WO2003082202A3 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 03/23/2006 | WO2003049602A3 Diagnostic methods for protein profiling |
| 03/23/2006 | US20060064789 Wheat variety XW03X |
| 03/23/2006 | US20060064788 Cotton cultivar 05X648DR |
| 03/23/2006 | US20060064787 comprising desired trait of: male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism and resistance to bacterial, fungal or viral disease; producing seeds and plants by crossing a plant of invention with another cotton plant |
| 03/23/2006 | US20060064786 Isopentenyl transferase sequences and methods of use |
| 03/23/2006 | US20060064785 Transgenic plant comprising an exogenous nucleic acid; modulation of hormone levels prior to the onset of stress provides plants with better stress tolerance. |
| 03/23/2006 | US20060064784 Nucleic acid sequences encoding proteins associated with abiotic stress response |
| 03/23/2006 | US20060064783 Increasing the expression level of pyruvate orthophosphate dikinase in a C4 plant such as corn by transformation using an expression cassette that includes a promoter, a C4 plant genomic gene, under control of the promoter, encoding an enzyme constituting a photosynthetic pathway, and a terminator. |
| 03/23/2006 | US20060064782 Production of antibodies |
| 03/23/2006 | US20060064779 Nucleic acid of given sequence; linked to promoter that drives oxygenase expression in cell; improves agronomic properties of maize, barley, wheat, rice |
| 03/23/2006 | US20060064778 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 03/23/2006 | US20060064777 Promoter molecules for use in plants |
| 03/23/2006 | US20060064776 Oil enhancing genes; diacylglycerol acyltransferase, phosphatidic acid phosphatase, and leucoanthocyanidin dioxygenase; transgenic seeds, cells, plants; feeds |
| 03/23/2006 | US20060064775 Method for increasing resistance against stress factors in plants |
| 03/23/2006 | US20060064774 Eukaryotic translaton initiation factor gene regulatory elements for use in plants |
| 03/23/2006 | US20060064773 Cell cycle polynucleotides and polypeptides and methods of use |
| 03/23/2006 | US20060064772 Maize seed with synergistically enhanced lysine content |
| 03/23/2006 | US20060064770 Methods for identifying a cell or an embryo carrying a Y chromosome |
| 03/23/2006 | US20060064769 Conditional disruption of Dicer1 in cell lines and non-human mammals |
| 03/23/2006 | US20060064767 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 03/23/2006 | US20060064766 Histamine receptor h3 modified transgenic mice |
| 03/23/2006 | US20060064765 Obesity gene |
| 03/23/2006 | US20060064764 Increasing gamete production with a gene switch |
| 03/23/2006 | US20060064763 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063733 Methods of reducing an immune response |
| 03/23/2006 | US20060063731 In vivo inhibition of hepatitis B virus |
| 03/23/2006 | US20060063730 Enhanced antisense oligonucleotides |
| 03/23/2006 | US20060063729 Ocular gene therapy |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060063727 Tr4/tr2 response elements |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060063711 Use of sglt homolog |
| 03/23/2006 | US20060063709 Nuclear factors associated with transcriptional regulation |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063261 Production of vaccines |
| 03/23/2006 | US20060063260 Method for producing a support carrying immobilized viruses, and the use of such a support |
| 03/23/2006 | US20060063259 Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination |
| 03/23/2006 | US20060063258 Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders |
| 03/23/2006 | US20060063257 complexing nucleic acids with cationic polymers to form complexes used for delivery of DNA to mammal cells |
| 03/23/2006 | US20060063250 Use of modified novirhabdoviruses to obtain vaccines |
| 03/23/2006 | US20060063249 Human cathepsin |
| 03/23/2006 | US20060063247 Increased thermostability, photostability, and water solubility |
| 03/23/2006 | US20060063245 Novel human enzymes and polynucleotides encoding the same |
| 03/23/2006 | US20060063244 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 03/23/2006 | US20060063243 Cloning and expression of microbial phytase |
| 03/23/2006 | US20060063240 Introducing into the chromosome of the bacterium a set of in vitro constructed DNA fragments which contain regulatory elements for gene expression instead of the native elements of the regulatory region of the gene, and selecting the colonies with increased L-amino acid productivity |
| 03/23/2006 | US20060063238 Method for the preparation of L-amino acids from D-amino acids |
| 03/23/2006 | US20060063237 Biologically pure bacterial cultures; alginate is produced in large amounts and with a certain determined content of mannuronate and guluronate residues; high yielding |
| 03/23/2006 | US20060063235 DNA encoding the human serine protease C-E |
| 03/23/2006 | US20060063232 Host-vector system for antibiotic-free CoIE1 plasmid propagation |
| 03/23/2006 | US20060063231 Compositions and methods for protein production |
| 03/23/2006 | US20060063227 Secreted proteins and polynucleotides encoding them |
| 03/23/2006 | US20060063204 such as annexins, natrietic precursor protein, and enolase; high speed immunoassay; for early detection and differentiation of stable/unstable angina and myocardial infarction |
| 03/23/2006 | US20060063203 Vascular endothelial cell growth factor variants and uses thereof |
| 03/23/2006 | US20060063201 Crystals of the Fc region of immunoglobulin epsilon heavy chain protein |
| 03/23/2006 | US20060063194 Methods and probes for the detection of cancer |
| 03/23/2006 | US20060063192 Nucleic acid sequencing by Raman monitoring of molecular deconstruction |
| 03/23/2006 | US20060063191 Detecting nucleic acid deletion sequences |
| 03/23/2006 | US20060063182 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria |
| 03/23/2006 | US20060063174 MicroRNA vectors |
| 03/23/2006 | US20060063173 Charge switch nucleotides |
| 03/23/2006 | US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample |